.Merck beats profits expectations, brings up purchases outlook on powerful requirement for top medications like Keytruda CNBCMerck & Co. (MRK United States) Defeats Revenue Forecasts as Keytruda Sales Increase BloombergMerck Inventory: Pharma Giant Posts Solid Outcomes, Yet Expectation Drops Short Financier's Organization DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps profit as well as sales assumptions in the middle of Keytruda strong point, however gives blended full-year expectation MarketWatch.